Association between antihypertensive medicine use and risk of ovarian cancer in women aged 50 years and older
Publication Details
Tuesley, K.,
Spilsbury, K.,
Webb, P.,
Protani, M.,
Dixon-Suen, S.,
Pearson, S.,
Donovan, P.,
Coory, M.,
Steer, C.,
Stewart, L.,
Pandeya, N.,
&
Jordan, S.
(2023).
Association between antihypertensive medicine use and risk of ovarian cancer in women aged 50 years and older.
Cancer Epidemiology: the international journal of cancer epidemiology, detection and prevention, 86.
Abstract
Background: Epithelial ovarian cancer (EOC) has few modifiable risk factors. There is evidence that some antihypertensive medicines may have cancer preventive and/or therapeutic actions; therefore, we assessed the associations between use of different antihypertensive medicines and risk of specific EOC histotypes.
Methods: Our nested case-control study of linked administrative health data included 6070 Australian women aged over 50 years diagnosed with EOC from 2004 to 2013, and 30,337 matched controls. We used multivariable conditional logistic regression to estimate odds ratios (ORs) and 95 % confidence intervals (CIs) for the association between ever use of each antihypertensive medicine group, including beta-adrenergic blockers, angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, calcium channel blockers, diuretics, and alpha blockers, and the risk of EOC overall and separately for the serous, endometrioid, mucinous, clear cell and other histotypes.
Results: We found that most antihypertensive medicines were not associated with risk of EOC. However, women who used calcium channel blockers had a reduced risk of serous EOC (OR= 0.89, 95 % CI:0.81,0.98) and use of combination thiazide and potassium-sparing diuretics was associated with an increased risk of endometroid EOC (OR= 2.09, 95 % CI:1.15,3.82).
Conclusion: Our results provide little support for a chemo-preventive role for most antihypertensives, however, the histotype-specific associations we found warrant further investigation.
Keywords
Antihypertensive agents, Adrenergic beta-antagonists, Diuretics, Calcium channel blockers
Link to Publisher Version (URL)
